Rubi Burlage, Ph.D. is Associate Vice President, Sterile Product Development at Merck & Co., Inc. In this role, Rubi is responsible for leadership of Merck’s sterile small molecule, biologics, and vaccine drug product formulation and process development. In previous roles, Rubi has served as Executive Director, Sterile Drug Product Commercialization within Merck’s manufacturing division leading commercialization of Merck’s sterile therapeutic and vaccines drug products. She is a co-author on several publications and co-inventor on 3 patents. Rubi earned a B.S. from India and Ph.D. from The University of Iowa. Dr. Burlage is a member of the American Association of Pharmaceutical Scientists (AAPS) and member of the Drug Product Leadership Group for the International Consortium for Innovation & Quality in Pharmaceutical Development (IQ), and serves on the R&D Council of New Jersey as Member of the Board.
Disclosure information not submitted.
Industry Plenary Lecture IV: Rubi Burlage
Thursday, July 17, 2025
12:00 PM - 1:00 PM EDT
